These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 20240017)

  • 1. Immunity to yellow fever five years after vaccination.
    ANDERSON CR; GAST-GALVIS A
    Am J Hyg; 1947 May; 45(3):302-4. PubMed ID: 20240017
    [No Abstract]   [Full Text] [Related]  

  • 2. Neutralizing and haemagglutination-inhibiting antibodies to yellow fever 17 years after vaccination with 17D vaccine.
    GROOT H; RIBERIRO RB
    Bull World Health Organ; 1962; 27(6):699-707. PubMed ID: 13950710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunity to yellow fever 6 years after vaccination.
    DICK GW; SMITHBURN KC
    Am J Trop Med Hyg; 1949 Jan; 29(1):57-61. PubMed ID: 18110333
    [No Abstract]   [Full Text] [Related]  

  • 4. Additional observations on the duration of humoral immunity following vaccination with the 17D strain of yellow fever virus.
    FOX JP; FONSECA DA CUNHA J; KOSSOBUDZKI SL
    Am J Hyg; 1948 Jan; 47(1):64-70. PubMed ID: 18921440
    [No Abstract]   [Full Text] [Related]  

  • 5. Coexistence of the antibodies of yellow fever and Weil's disease in human serum.
    PACKCHANIAN A; PRICE TG
    Tex Rep Biol Med; 1946; 4(3):364-7. PubMed ID: 20999059
    [No Abstract]   [Full Text] [Related]  

  • 6. [The current state of vaccination against yellow fever or yellow fever vaccination].
    STEFANOPOULO GJ
    Rev Med Fr; 1946 Jan; 27():3-8. PubMed ID: 21014862
    [No Abstract]   [Full Text] [Related]  

  • 7. [Vaccination against yellow fever (yellow fever vaccination)].
    LAUTERBURG-BONJOUR M
    Med Hyg (Geneve); 1947 Jan; 5(90):4. PubMed ID: 20342193
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunological studies with group B arthropod-borne viruses. IV. Persistence of yellow fever antibodies following vaccination with 17D strain yellow fever vaccine.
    ROSENZWEIG EC; BABIONE RW; WISSEMAN CL
    Am J Trop Med Hyg; 1963 Mar; 12():230-5. PubMed ID: 13975014
    [No Abstract]   [Full Text] [Related]  

  • 9. Should yellow fever vaccine be included in the expanded program of immunization in Africa? A cost-effectiveness analysis for Nigeria.
    Monath TP; Nasidi A
    Am J Trop Med Hyg; 1993 Feb; 48(2):274-99. PubMed ID: 8447531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology and incubation period of jaundice following yellow fever vaccination.
    FREEMAN G
    Am J Trop Med Hyg; 1946 Jan; 26():15-32. PubMed ID: 21018582
    [No Abstract]   [Full Text] [Related]  

  • 11. Serological reactions in Rhesus monkeys inoculated with the 17D strain of yellow fever virus.
    GROOT H
    Bull World Health Organ; 1962; 27(6):709-15. PubMed ID: 13950709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duration of post-vaccination immunity against yellow fever in adults.
    Collaborative group for studies on yellow fever vaccines
    Vaccine; 2014 Sep; 32(39):4977-84. PubMed ID: 25090646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A comparison of the serological effects of classical cholera vaccine and of purified fraction vaccine, with or without simultaneous yellow fever vaccine (author's transl)].
    Gateff C; Dodin A; Wiart J
    Ann Microbiol (Paris); 1975; 126(2):231-46. PubMed ID: 1098542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yellow fever vaccination in the Americas.
    Bull Pan Am Health Organ; 1984; 18(2):188-92. PubMed ID: 6207882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination with Replication Deficient Adenovectors Encoding YF-17D Antigens Induces Long-Lasting Protection from Severe Yellow Fever Virus Infection in Mice.
    Bassi MR; Larsen MA; Kongsgaard M; Rasmussen M; Buus S; Stryhn A; Thomsen AR; Christensen JP
    PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004464. PubMed ID: 26886513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunity to yellow fever nine years after vaccination with 17D vaccine.
    DICK GW; GEE FL
    Trans R Soc Trop Med Hyg; 1952 Jul; 46(4):449-58. PubMed ID: 14958824
    [No Abstract]   [Full Text] [Related]  

  • 17. Yellow Fever Vaccination of a Primary Vaccinee During Adalimumab Therapy.
    Nash ER; Brand M; Chalkias S
    J Travel Med; 2015; 22(4):279-81. PubMed ID: 25922988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The early cellular signatures of protective immunity induced by live viral vaccination.
    Kohler S; Bethke N; Böthe M; Sommerick S; Frentsch M; Romagnani C; Niedrig M; Thiel A
    Eur J Immunol; 2012 Sep; 42(9):2363-73. PubMed ID: 22733156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CIRCULATING VIRUS, INTERFERON AND ANTIBODY AFTER VACCINATION WITH THE 17-D STRAIN OF YELLOW-FEVER VIRUS.
    WHEELOCK EF; SIBLEY WA
    N Engl J Med; 1965 Jul; 273():194-8. PubMed ID: 14306335
    [No Abstract]   [Full Text] [Related]  

  • 20. Intradermal vaccination to protect against yellow fever and influenza.
    Roukens AH; Gelinck LB; Visser LG
    Curr Top Microbiol Immunol; 2012; 351():159-79. PubMed ID: 21416266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.